REPL•benzinga•
Replimune Group Inc. Expects Enrollment Of First Patients In Phase 3 Confirmatory Trial Of RP1 In Advanced Melanoma In 2H 2024
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2024 by benzinga